Errores de medicación en el Servicio de Medicina de un hospital de alta complejidad
Author
dc.contributor.author
Smith M., Ann-Loren
Author
dc.contributor.author
Ruiz A., Inés
es_CL
Author
dc.contributor.author
Jirón Aliste, Marcela
es_CL
Admission date
dc.date.accessioned
2015-01-08T02:35:14Z
Available date
dc.date.available
2015-01-08T02:35:14Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
Rev. Méd. Chile vol.142 no.1 Santiago ene. 2014
en_US
Identifier
dc.identifier.issn
0034-9887
Identifier
dc.identifier.other
http://dx.doi.org/10.4067/S0034-98872014000100007
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/121966
General note
dc.description
Artículo de publicación SciELO
en_US
Abstract
dc.description.abstract
Background: Patients admitted to internal medicine services receive multiple drugs and thus are at risk of medication errors. Aim: To determine the frequency of medication errors (ME) among patients admitted to an internal medicine service of a high complexity hospital. Material and Methods: A prospective observational study conducted in 225 patients admitted to an internal medicine service. Each stage of drug utilization system (prescription, transcription, dispensing, preparation and administration) was directly observed by trained pharmacists not related to hospital staff during three months. ME were described and categorized according to the National Coordinating Council for Medication Error Reporting and Prevention. In each stage of medication use, the frequency of ME and their characteristics were determined. Results: A total of 454 drugs were prescribed to the studied patients. In 138 (30,4%) indications, at least one ME occurred, involving 67 (29,8%) patients. Twenty four percent of detected ME occurred during administration, mainly due to wrong time schedules. Anticoagulants were the therapeutic group with the highest occurrence of ME. Conclusions: At least one ME occurred in approximately one third of patients studied, especially during the administration stage. These errors could affect the medication safety and avoid achieving therapeutic goals. Strategies to improve the quality and safe use of medications can be implemented using this information.